Edwards Lifesciences (EW) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.05% |
| Dec 31, 2025 | 13.61% |
| Sep 30, 2025 | 14.31% |
| Jun 30, 2025 | 15.99% |
| Mar 31, 2025 | 16.47% |
| Dec 31, 2024 | 15.01% |
| Sep 30, 2024 | 16.80% |
| Jun 30, 2024 | 12.62% |
| Mar 31, 2024 | 12.23% |
| Dec 31, 2023 | 11.95% |
| Sep 30, 2023 | 9.48% |
| Jun 30, 2023 | 9.63% |
| Mar 31, 2023 | 8.23% |
| Dec 31, 2022 | 7.91% |
| Sep 30, 2022 | 9.50% |
| Jun 30, 2022 | 10.39% |
| Mar 31, 2022 | 11.99% |
| Dec 31, 2021 | 13.52% |
| Sep 30, 2021 | 13.47% |
| Jun 30, 2021 | 13.59% |
| Mar 31, 2021 | 13.36% |
| Dec 31, 2020 | 12.28% |
| Sep 30, 2020 | 11.90% |
| Jun 30, 2020 | 12.23% |
| Mar 31, 2020 | 11.74% |
| Dec 31, 2019 | 12.99% |
| Sep 30, 2019 | 12.24% |
| Jun 30, 2019 | 10.87% |
| Mar 31, 2019 | 15.58% |
| Dec 31, 2018 | 14.46% |
| Sep 30, 2018 | 18.68% |
| Jun 30, 2018 | 19.43% |
| Mar 31, 2018 | 20.46% |
| Dec 31, 2017 | 20.60% |
| Sep 30, 2017 | 20.11% |
| Jun 30, 2017 | 19.88% |
| Mar 31, 2017 | 18.99% |
| Dec 31, 2016 | 17.89% |
| Sep 30, 2016 | 16.95% |
| Jun 30, 2016 | 15.14% |
| Mar 31, 2016 | 14.82% |
| Dec 31, 2015 | 18.08% |
| Sep 30, 2015 | 17.57% |
| Jun 30, 2015 | 17.06% |
| Dec 31, 2014 | 16.87% |